Table 3.
Diagnostic performance of the clinical model and the radiomics nomogram in identifying FPT candidate patients
Model | Group | SPE | SEN | ACC | AUC (95% CI) | P value* |
---|---|---|---|---|---|---|
Clinical model | Primary | 72.6% | 53.3% | 68.9% | 0.63 (0.53-0.73) | |
Validation 1 | 68.6% | 54.5% | 66.7% | 0.62 (0.45-0.78) | ||
Validation 2 | 85.0% | 54.5% | 78.4% | 0.69 (0.53-0.86) | ||
Radiomics nomogram | Primary | 75.0% | 86.7% | 77.2% | 0.86 (0.80-0.93) | <0.001 |
Validation 1 | 65.7% | 90.9% | 69.2% | 0.82 (0.71-0.93) | 0.048 | |
Validation 2 | 75.0% | 100% | 80.3% | 0.94 (0.87-1.00) | 0.002 |
comparison between clinical model with radiomics nomogram in the primary group and the validation groups.
ACC, accuracy; AUC, area under the curve; CI, confidence interval; SEN, sensitivity; SPE, specificity.